{
  "docId": "019de076-b194-750c-a1e9-eae1d42bc6f5",
  "docSlug": "9fdf48e9810bc95033985664c53d0e5a",
  "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
  "authorId": "mainz-biomed-nv",
  "authorName": "Mainz Biomed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 24,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "why_now",
  "function": "argue_timing",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "The slide uses data from a 2022 JNCI study to justify the clinical importance of AA detection sensitivity.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-b194-750c-a1e9-eae1d42bc6f5/11",
  "deckHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5",
  "deckJsonHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5.json",
  "deckAnchorHref": "/decks/019de076-b194-750c-a1e9-eae1d42bc6f5#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.18,
        "w": 0.43,
        "x": 0.052,
        "y": 0.00617
      },
      "kind": "callout",
      "text": "76% sensitivity for AA: Reduction in CRC incidence by 57% Reduction in CRC mortality by 67%",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "099d3e99-658f-4909-afe1-3601b9249640",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.43,
        "x": 0.052,
        "y": 0.00425
      },
      "kind": "callout",
      "text": "21% sensitivity for AA: Reduction of CRC incidence by 30% Reduction of CRC mortality by 47%",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2f7fe475-7005-496d-8bc5-85ae9fb6605f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.033,
        "w": 0.45,
        "x": 0.052,
        "y": 0.00383
      },
      "kind": "list",
      "text": "If a screening tests in 45yr olds and above resulted in:",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "830414b5-4fd0-440a-a98e-0d6e6cb6dfc0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.083,
        "w": 0.792,
        "x": 0.052,
        "y": 0.00242
      },
      "kind": "paragraph",
      "text": "Discussion of CMS decision memo on thresholds of 74% sensitivity, 90% specificity for blood-based screening for CRC. No thresholds set for detection of AA.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "abd44b05-1ffc-481c-8b44-c311db2664b4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.052,
        "y": 0.00817
      },
      "kind": "source-note",
      "text": "Ladabaum U, et al. Counting Advanced Precancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity, JNCI: Journal of the National Cancer Institute, Volume 114, Issue 7, July 2022, Pages 1040-1043",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "86d583b8-823f-4507-8e5e-c2a5f1862b9d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.048,
        "w": 0.872,
        "x": 0.052,
        "y": 0.00155
      },
      "kind": "title",
      "text": "Including AAs detection in screening tests significantly reduces both incidence and mortality",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d745961a-9406-400f-9c7f-4fd15116e263",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.083,
        "w": 0.798,
        "x": 0.048,
        "y": 0.033
      },
      "kind": "title",
      "text": "Impact of AA sensitivity on CRC Mortality and Incidents Rates",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eaa00738-37b7-444f-86e1-24f14d33d91c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before/after framing",
      "slug": "before-after-framing",
      "agent": null,
      "layer": "slide",
      "matchId": "116bde0a-cdda-479a-b2dd-efdbdb0f70eb",
      "evidence": "callout/primary: 21% sensitivity for AA: Reduction of CRC incidence by 30% Reduction of CRC mortality by 47%",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "evidence-matrix",
      "slug": null,
      "matchId": "6413de2e-30d6-47bb-a83c-3f7e2711090d",
      "evidence": "Presents comparative outcomes based on sensitivity variables",
      "confidence": 0.7
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 11,
      "from": 10,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "2e5f5f19-b542-4f7b-b668-a00aa4389c6f",
      "evidence": "Slides 10 and 11 present the problem and the benefits of including AAs detection in screening tests",
      "position": 0,
      "objective": "The cost of inaction in CRC screening",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 11,
      "from": 11,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "7cf3075b-054e-4d1a-93de-425d0a585948",
      "evidence": "Slide 11 presents the why now section",
      "position": 1,
      "objective": "Why now is the time for Mainz Biomed's solution",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}